The purpose of IND-enabling studies is to secure approval to conduct the first-in-human clinical trials with a new drug. The goal of the IND application section on pharmacology and toxicology (PT) is to show with safety and pharmacokinetic data, that the drug candidate is safe for clinical trials. We support companies applying for the IND with a combination of in vitro assays and data interpretation. For more details please visit the website today!!
